Navigation Links
WuXi PharmaTech Announces First-Quarter 2011 Results
Date:5/10/2011

marketing expenses

(1,958)

(2,282)

(14%)General and administrative expenses

(12,896)

(10,701)

21%Total operating expenses(14,854)

(12,983)

14%Operating income 19,840

17,435

14%Other income (expenses), net:Other income (expenses), net

1,627

183

*Interest income (expenses), net

831

98

*Total other income (expenses), net2,458

281

*Income before income taxes22,298

17,716

26%Income tax expense

(4,074)

(2,199)

85%Net income18,224

15,517

17%Basic net earnings per ADS0.26

0.22

15%Diluted net earnings per ADS0.24

0.21

16%Weighted average ADS outstanding—basic 70,419,377

69,075,025Weighted average ADS outstanding—diluted74,944,373

74,230,526*  Not meaningful or greater than 100%WUXI PHARMATECH (CAYMAN) INC.RECONCILIATION OF GAAP TO Non-GAAP(in thousands of U.S. dollars, except ADS data and par value data) Three Months Ended March 31,20112010% ChangeGAAP gross profit34,694

30,418

14%GAAP gross margin37%

38%Adjustments:Share-based compensation

975

889

10%Amortization of acquired intangible assets

355

764

(54%)Non-GAAP gross profit36,024

32,071

12%Non-GAAP gross margin39%

40%GAAP operating income19,840

17,435

14%GAAP operating margin21%

22%Adjustments:Share-based compensation

2,937

2,322

26%Amortization of acquired intangible assets

355

764

(54%)Non-GAAP operating income23,132

20,521

13%Non-GAAP operating margin25%

25%GAAP net income18,224

15,517

17%GAAP net margin19%

19%Adjustments:Share-based compensation

2,937

2,322

26%Amortization of acquired intangible as
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
3. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
5. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
7. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
8. WuXi PharmaTech Announces First-Quarter 2010 Results
9. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
10. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
11. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced it ... adults suffering from the severe cold weather that has gripped ... to helping those in need; so to support these emergency ... up to $250,000, which could mean up to $500,000 in ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide ... from the Journal of Drugs in Dermatology ... Conference (ODAC). The event is January 17-20, 2014, at the Omni ... . The ODAC is a distinguished ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... against cancers and infectious diseases, announced today that the ... technology at the 14th Annual Meeting of the American ... May 18-21 in Seattle, Washington at the Washington State ...
... Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" ... first quarter ended March 31, 2011. F ... Highlights Total revenue increased to $9.4 million ... Net cash provided by operating activities was approximately $2.6 ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 2Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 3Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 4China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 2China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 3China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 4China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 5China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 6China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 7China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 8
(Date:7/10/2014)... electronic health record becomes widespread across the United States, ... Care Act, the quantity of clinical data that will ... dramatically increase. Additionally, experts in healthcare have become ... of data for the purpose of gleaning insights that ... care a process that is known as big ...
(Date:7/10/2014)... Fischer HealthDay Reporter THURSDAY, ... ease the hot flashes that often accompany menopause, new research ... 50 percent of menopausal women, said Dr. Taraneh Shirazian, an ... the Icahn School of Medicine at Mount Sinai Hospital in ... than 10 hot flashes a day, and she added that ...
(Date:7/10/2014)... (Boston) Emergency Medical Service (EMS) responders felt better ... receiving focused tactical training according to a new study ... This is the first study to specifically examine the ... scene where a shooter has not yet been neutralized ... , Incidents such as the Columbine High School shooting, ...
(Date:7/10/2014)... the "Mississippi baby" an infant seemingly cured of HIV ... remission of HIV infection in The New England Journal ... after more than two years of not taking antiretroviral therapy ... and researchers involved in the case. , "Certainly, ... child, the medical staff involved in the child,s care, and ...
(Date:7/10/2014)... University of Huddersfield could help to improve the quality ... such as butter, mayonnaise, yoghurt and fruit drinks ... profile for her work. , Katerina gained her MSc ... and now she has embarked on research for a ... she is investigating the potential of carbohydrates extracted from ...
Breaking Medicine News(10 mins):Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:Active shooter training increases comfort level of emergency responders 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:World interest in research work on the benefits of the Okra plant 2
... short of water supply pushing the civic authorities to ration ... population needs eight million gallons of water daily, it has ... Corporation. ,Civic officials said that starting Thursday, water ... ,According to one estimate, 1.5 million gallons of ...
... Smt. Panabaka Lakshmi Inaugurated the Orientation and Capacity Building ... on “Strategies for Conservation and Cultivation of Medicinal Plants” ... that our strategies and action plans should focus not ... in the forest areas but promote cultivation of medicinal ...
... the University of Nottingham are exploring the medical condition which ... ,David Humes of the Division of Gastroenterology, in ... to understand pain, has begun to delve into pain caused ... ,Dr David Humes said: "Our aim is to discover ...
... The World Health Organization (WHO) Thursday expressed alarm over ... motorcycles in Asia//, warning that the situation has become ... that young motorcyclists make up a significant percentage of ... countries, such as Cambodia and Malaysia. ,"Factors ...
... is cigarette smoking there is probably misuse of alcohol ... Medicine researchers in the Archives// of Internal Medicine. ... as a clinical indicator for alcohol misuse, which presents ... McKee, assistant professor of psychiatry. ,She said ...
... deficiency is common and cancer risk is higher among those ... , ,Epidemiological and basic science research, as well as ... preventive and therapeutic cancer agent, suggest that vitamin D deficiency ... types of cancer and increase the likelihood of numerous complications ...
Cached Medicine News:Health News:Exports Of Herbal & Dietary Products Has Huge Potential 2Health News:Smoking Indicator of Alcohol Misuse 2Health News:Deficiency in Vitamin D Increases the Risk of Cancer 2
... interoperative placement to stent the ... and continent urinary diversions. Supplied ... for one-time use. CAUTION: Periodic ... not remain indwelling more than ...
... a device that provides effective cutting and simultaneous ... to provide the urologist with the same touch ... the approximate speed and the same ease of ... but with a 45% greater zone of ...
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: